IRIS
BITTONI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.183
EU - Europa 983
AS - Asia 328
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.575
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.183
IT - Italia 241
UA - Ucraina 195
SE - Svezia 156
IE - Irlanda 118
CN - Cina 103
DE - Germania 93
TR - Turchia 89
SG - Singapore 84
DK - Danimarca 72
CI - Costa d'Avorio 56
FI - Finlandia 47
KR - Corea 39
GB - Regno Unito 27
MA - Marocco 19
FR - Francia 18
IN - India 9
BE - Belgio 8
NL - Olanda 4
DZ - Algeria 3
EU - Europa 3
JP - Giappone 2
RO - Romania 2
VN - Vietnam 2
CZ - Repubblica Ceca 1
RS - Serbia 1
Totale 3.575
Salva come PNG Salva come JPEG
Città #
Chandler 286
Jacksonville 214
Fairfield 210
Ashburn 156
Wilmington 133
Boardman 118
Dublin 118
Woodbridge 103
Ann Arbor 95
New York 91
Seattle 90
Houston 85
Des Moines 74
Cambridge 72
Centro 67
Abidjan 56
Lawrence 47
Princeton 47
San Mateo 47
Turin 33
Beijing 23
Singapore 20
San Diego 18
Helsinki 9
Pune 9
Brussels 8
London 8
Guangzhou 7
Wuhan 7
Wuxi 7
Cagliari 6
Washington 6
Rome 5
Falls Church 4
Los Angeles 4
Milan 4
New Bedfont 4
Prescot 4
Yiwu 4
Cupra Marittima 3
Dallas 3
Fermignano 3
Isola Rizza 3
Izmir 3
Kilburn 3
Modena 3
Nanjing 3
Norwalk 3
Shanghai 3
Shenzhen 3
Torre Del Greco 3
Amsterdam 2
Ancona 2
Bracigliano 2
Caserta 2
Chengdu 2
Citta 2
Como 2
Florence 2
Hanoi 2
Hounslow 2
Isola della Scala 2
Jinhua 2
Kagoya 2
Roseto degli Abruzzi 2
San Francisco 2
Venice 2
Acerra 1
Acton 1
Ascoli Piceno 1
Buffalo 1
Campogalliano 1
Chicago 1
Chiswick 1
Chizhou 1
Clifton 1
Dalian 1
Dongyang 1
Falkenstein 1
Fayetteville 1
Frankfurt (Oder) 1
Frankfurt am Main 1
Groningen 1
Hanover 1
Jiaxing 1
Jinan 1
Macerata 1
Marche 1
Olomouc 1
Porto 1
Qingdao 1
Quanzhou 1
San Severino Marche 1
Santa Maria a Monte 1
Seoul 1
Stamford 1
Tiantai Chengguanzhen 1
Villa Verucchio 1
Zibo 1
Totale 2.399
Salva come PNG Salva come JPEG
Nome #
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 131
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 118
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 117
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 105
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 104
Optimal management of resected gastric cancer 101
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 99
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 96
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 93
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy 93
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target 90
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 85
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival 85
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 83
HER family receptor expression and prognosis in pancreatic cancer 83
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 83
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 82
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 81
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 81
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 81
Medical treatment for cholangiocarcinoma 80
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 78
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 78
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 75
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 74
Yes-associated protein and immunosuppressive microenvironment in pancreatic cancer development: A new strategy to improve immunotherapy efficacy? 72
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. 70
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 70
Panitumumab for the treatment of metastatic colorectal cancer: A review 70
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 70
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 69
Trattamento del carcinoma del pancreas. Attualità e prospettive 68
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 66
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 65
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 65
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 65
The challenge of targeted therapies for gastric cancer patients: The beginning of a long journey 64
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 63
ASSOCIAZIONE TRA STATO MUTAZIONALE DI KRAS E PATTERN DI ESPRESSIONE GENETICA NEL CARCINOMA DEL PANCREAS 59
Selecting the best treatment for an individual patient. 59
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. 58
Doses of capecitabine and oral vinorelbine are not relevant for efficacy in breast cancer patients: an analysis of dose intensity. 56
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 56
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 54
Palliative treatment 51
Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward? 46
Sicurezza degli ESA: sopravvivenza e stimolazione recettoriale/progressione tumorale 43
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 29
Totale 3.664
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020226 0 0 0 1 47 1 44 6 43 10 15 59
2020/2021872 49 84 114 36 110 59 62 59 72 105 80 42
2021/2022389 29 94 6 8 5 29 17 23 17 54 29 78
2022/2023854 60 117 59 62 62 141 1 46 193 10 80 23
2023/2024501 74 8 45 61 69 131 5 20 3 8 10 67
2024/2025250 148 77 20 5 0 0 0 0 0 0 0 0
Totale 3.664